Author

Andrea N. Georgiou

University of CyprusORCID 0000-0003-4214-3678Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Anna OnisiforouiD· 1 shared Panos ZanosiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Anna OnisiforouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioinformaticsbioRxivPreprintMar 14, 2025

Metformin Shows Greater Potential Than Semaglutide in Reducing Alzheimer's Risk in Diabetes Type II via Dual Actions: Tackling Disease Pathways and Environmental Herpesvirus Triggers

Andrea N. Georgiou, Panos Zanos, Anna Onisiforou

This study compares Metformin and Semaglutide for Alzheimer's risk reduction in Type II Diabetes using network pharmacology, MR, and transcriptomics, finding Metformin more effective through dual mechanisms.

3 citations

humanGWAS summary statistics

𝕏 PostBluesky